Search results for: Cambridge Biomedical Campus

Original Source An international team of scientists, led by researchers based at the Cambridge Research Institute, have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment, germcitabine. The study, published in the journal Science today,…

Original Source Cancer Research UK scientists have discovered the molecular basis for tamoxifen response in breast cancer cells - and the reason why some women can develop resistance to the treatment, according to a study published in Nature*. Tamoxifen is given to most women for…